rs730882249
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004722.4(AP4M1):c.952C>T(p.Arg318*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,461,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004722.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251488Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135922
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727236
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 50 Pathogenic:5
Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PVS1,PM2,PM3,(PP1) -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000183357 /PMID: 24700674). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
- -
- -
not provided Pathogenic:2
- -
- -
Spastic paraplegia Pathogenic:1
- -
Hypoplasia of the corpus callosum;C0557874:Global developmental delay;C4025616:CNS hypomyelination;C4551563:Microcephaly;C4551584:Brain atrophy Pathogenic:1
- -
AP4M1-related disorder Pathogenic:1
The AP4M1 c.952C>T variant is predicted to result in premature protein termination (p.Arg318*). This variant was reported in individuals with autosomal recessive spastic tetraplegia (Tüysüz et al. 2014. PubMed ID: 24700674; Table S1, Monies et al. 2019. PubMed ID: 31130284; Table S2, Dong et al. 2020. PubMed ID: 32005694). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-99703604-C-T). Nonsense variants in AP4M1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at